16-7676798-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_018723.4(RBFOX1):c.955G>T(p.Ala319Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,094 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A319T) has been classified as Uncertain significance.
Frequency
Consequence
NM_018723.4 missense
Scores
Clinical Significance
Conservation
Publications
- epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- autism susceptibility 1Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018723.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | NM_018723.4 | MANE Select | c.955G>T | p.Ala319Ser | missense | Exon 14 of 16 | NP_061193.2 | ||
| RBFOX1 | NM_145893.3 | MANE Plus Clinical | c.1018G>T | p.Ala340Ser | missense | Exon 11 of 14 | NP_665900.1 | ||
| RBFOX1 | NM_001415887.1 | c.1552G>T | p.Ala518Ser | missense | Exon 17 of 20 | NP_001402816.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | ENST00000550418.6 | TSL:1 MANE Select | c.955G>T | p.Ala319Ser | missense | Exon 14 of 16 | ENSP00000450031.1 | ||
| RBFOX1 | ENST00000355637.9 | TSL:1 MANE Plus Clinical | c.1018G>T | p.Ala340Ser | missense | Exon 11 of 14 | ENSP00000347855.4 | ||
| RBFOX1 | ENST00000311745.9 | TSL:1 | c.1018G>T | p.Ala340Ser | missense | Exon 11 of 13 | ENSP00000309117.5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251138 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461094Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726778 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy Uncertain:1
In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a RBFOX1-related disease. This sequence change replaces alanine with serine at codon 340 of the RBFOX1 protein (p.Ala340Ser). The alanine residue is moderately conserved and there is a moderate physicochemical difference between alanine and serine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at